The potential of oncolytic virus therapy for pancreatic cancer.
about
Mathematical modeling of tumor therapy with oncolytic viruses: regimes with complete tumor elimination within the framework of deterministic models.Adenoviral vectors for prodrug activation-based gene therapy for cancerMathematical modeling of tumor therapy with oncolytic viruses: effects of parametric heterogeneity on cell dynamics.Oncolytic activity of avian influenza virus in human pancreatic ductal adenocarcinoma cell lines.Seneca Valley virus, a systemically deliverable oncolytic picornavirus, and the treatment of neuroendocrine cancersCurrent good manufacturing practice production of an oncolytic recombinant vesicular stomatitis viral vector for cancer treatment.Combination of a fusogenic glycoprotein, pro-drug activation and oncolytic HSV as an intravesical therapy for superficial bladder cancerMyxoma virus sensitizes cancer cells to gemcitabine and is an effective oncolytic virotherapeutic in models of disseminated pancreatic cancer.New pancreatic carcinoma model for studying oncolytic adenoviruses in the permissive Syrian hamster.Development of nonhuman adenoviruses as vaccine vectors.Molecular mechanism of the "feedback loop" model of carcinogenesis.Extended disease-free interval of 6 years in a recurrent glioblastoma multiforme patient treated with G207 oncolytic viral therapy.Hypoxia- and radiation-induced overexpression of Smac by an adenoviral vector and its effects on cell cycle and apoptosis in MDA-MB-231 human breast cancer cells.Interventional endoscopic ultrasonography for pancreatic cancer.Vesicular stomatitis virus as an oncolytic agent against pancreatic ductal adenocarcinoma.Interventional endoscopic ultrasonography: present and future.A third-generation herpesvirus is effective against gastroesophageal cancer.Oncolytic adenoviral mutants with E1B19K gene deletions enhance gemcitabine-induced apoptosis in pancreatic carcinoma cells and anti-tumor efficacy in vivo.The E1B19K-deleted oncolytic adenovirus mutant AdΔ19K sensitizes pancreatic cancer cells to drug-induced DNA-damage by down-regulating Claspin and Mre11A tale of two targets: differential RNA selectivity of nucleobase-aminoglycoside conjugates.
P2860
Q25257260-79A527F8-FFB4-49EA-844B-1CE32C373F2DQ26860729-F8F50521-0EBB-4A32-83B8-373B59F9D09EQ33259239-ED4F8181-D92B-45B8-A3ED-09C71C3EDD01Q34059067-E638BACF-4F7D-4D17-B19A-8ABB3BFE3F58Q34707959-311999DA-7916-4B71-A9B7-D7903674C903Q34774805-97524CA2-BE54-4F63-83CF-DF3169D98211Q35739482-2B9F26AA-C4A0-4B44-9D08-FB46E526B440Q35876172-1FC553EF-6693-4C4E-A314-AEFDB5EE2669Q36209172-754E8D4E-6D4B-4AD4-8097-FB6FCE5B5CA3Q36317264-F300B643-F248-4A49-88A7-B4D708886D84Q36411807-F845B8A8-45B7-493B-A7E3-B6297CACACFBQ37031918-01B44C65-C10A-4181-90CC-E1A42EAADC0FQ37313184-7B846549-31C7-41E2-BD29-7D7B9945C0C6Q37878303-E8C2EE72-A5B0-40D8-9767-B07BD061F5FAQ39413447-B0212BA5-F995-4774-AEE8-2FC827F6E41AQ39595627-7C8E2C9D-948D-4A32-A324-7ED262C4A0AEQ39694724-C5F8B200-C95E-4CB9-A4D3-D46255964FA7Q39882822-D8158D9B-CB83-41D8-B2E2-30B507775F7BQ40913003-364D8E75-1300-4222-81AE-8D8D031933F1Q51144459-F3C198C0-9E63-4A23-9DE3-1D49AD26B4B6
P2860
The potential of oncolytic virus therapy for pancreatic cancer.
description
2005 nî lūn-bûn
@nan
2005 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
The potential of oncolytic virus therapy for pancreatic cancer.
@ast
The potential of oncolytic virus therapy for pancreatic cancer.
@en
The potential of oncolytic virus therapy for pancreatic cancer.
@nl
type
label
The potential of oncolytic virus therapy for pancreatic cancer.
@ast
The potential of oncolytic virus therapy for pancreatic cancer.
@en
The potential of oncolytic virus therapy for pancreatic cancer.
@nl
prefLabel
The potential of oncolytic virus therapy for pancreatic cancer.
@ast
The potential of oncolytic virus therapy for pancreatic cancer.
@en
The potential of oncolytic virus therapy for pancreatic cancer.
@nl
P2093
P356
P1433
P1476
The potential of oncolytic virus therapy for pancreatic cancer.
@en
P2093
Akimasa Nakao
Hideki Kasuya
Shin Takeda
Shuji Nomoto
P2888
P304
P356
10.1038/SJ.GT.3302461
P577
2005-09-01T00:00:00Z